Awareness • Early Detection • Treatment • Research • Survivorship

Andy Bonnett is Changing the Face of Lung cancer!

Physicians at the University of Colorado Hospital are finding startling success with medications that are made to match the genes of a particular lung cancer. The new strategy means the drugs work only on certain patients – but they can work really well. Researchers think the cancer-fighting drugs may tamp the disease for a few years, and then the cancers may mutate and find a way around the medication. But years of healthy living is fantastic for people who’ve been diagnosed with Stage 4 lung cancer, which has a five-year survival rate of less than 3 percent. Dr. Ross Camidge of UCH says patient Andy Bonnett is a prime example of what one of this new strategy of “personalized medicine” can do. Two years ago Bonnett was one of those Stage 4 lung cancer patients. He was, said Camidge, “a young man who had never smoked, led a very healthy life, developed increasing shortness of breath and pain, and was diagnosed with lung cancer in his mid-30s.”

Andy Bonnett is Changing the Face of Lung cancer! from TEAM DRAFT on Vimeo.